Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-03-000123
Filing Date
2003-02-06
Accepted
2003-02-06 15:59:31
Documents
2
Period of Report
2003-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K o08865e6vk.htm 6-K 16381
3 GRAPHIC o08865onco.gif GRAPHIC 3104
  Complete submission text file 0001130319-03-000123.txt   20987
Mailing Address
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 03542646
SIC: 2834 Pharmaceutical Preparations